drugset / Trial / NCT01350934
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate whether the once weekly administration of the combination tablet alendronate/vitamin D3 (FOSAMAX PLUS) will increase lumbar spine bone mineral density (BMD) more than the daily use of calcitriol.
Timeline
- Start
- 2011-06-19
- Primary completion
- 2013-01-10
- Completion
- 2013-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | 70 mg | Oral |
| Comparator | Calcitriol | Small molecule | 0.25 ug | Oral |
| Subject | Cholecalciferol | Other / unclassified | 5600 iu | Oral |